SOLVE FSHD is a foundation-backed venture philanthropy investor and health-focused capital allocator supporting research and therapeutic development for facioscapulohumeral muscular dystrophy. Associated with Chip Wilson and the House of Wilson, it backs biotechnology, life sciences, HealthTech and pharmaceutical companies developing neuromuscular-disease treatments, with activity in United States later-stage venture rounds and at least one co-led Series B financing.